Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAO TOS: Comparing Treatments for Acute Cough in URTI
NCT06907355Phase 4Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodropropizine, codeine and prospan in cough (4 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Change in cough severity at 48 hours. Started May 2025; status: completed.
02
Drugs
levodropropizinecodeineprospan
03
Conditions
cough
Beyond the preview
Go deeper on NCT06907355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907355.